TITLE

Vitamin D and Hypertension

AUTHOR(S)
Jafari, Tina; Paknahad, Zamzam
PUB. DATE
June 2014
SOURCE
Zahedan Journal of Research in Medical Sciences;Jun2014, Vol. 16 Issue 6, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Nowadays, hypertension is one of the most important causes of death all over the world because of its adverse effects on cardiovascular system. For this reason its study is very valuable. Vitamin D is one of the important factors that may influence blood pressure. Many studies have shown the modulatory effect of this vitamin on rennin-angiotensin system as well as its inhibitory effect on vascular smooth muscle hypertrophy. According to the fact that vitamin receptors are distributed in almost all organs of human body, we can't consider its role just as factor in calcium homeostasis. Therefore many other important roles could be attributed to it. So vitamin D deficiency could arise many problems. There are many causes for vitamin D deficiency. The most important is insufficient exposure to UV-B. In epidemiological studies the vitamin D deficiency is considered to be associated with high blood pressure, as emphasized in many cross-sectional studies. Concerning the cohort prospective studies, the relationship between vitamin D deficiency and hypertension is reported in some cases. The interventional studies about the association between vitamin D and hypertension are not many and the results are different or contradictory. Controversial results might be due to differences in dose of supplements or duration of supplement therapy. The aim of this systematic review is to assess the researches about the association between vitamin D deficiency and hypertension and discuss the power of them. This can be helpful to lighten the path to prospective investigations.
ACCESSION #
95770848

 

Related Articles

  • Risk conferred by FokI polymorphism of vitamin D receptor (VDR) gene for essential hypertension. Swapna, N.; Mohana Vamsi, U.; Usha, G.; Padma, T. // Indian Journal of Human Genetics;Sep-Dec2011, Vol. 17 Issue 3, p201 

    Background : The vitamin D receptor (VDR) gene serves as a good candidate gene for susceptibility to several diseases. The gene has a critical role in regulating the renin-angiotensin system (RAS) influencing the regulation of blood pressure. Hence determining the association of VDR...

  • Differential inducibility of angiotensin II AT2 receptor between SHR and WKY vascular smooth muscle cells. ICHIKI, TOSHIHIRO; KAMBAYASHI, YOSHIKAZU; INAGAMI, TADASHI // Kidney International Supplement;Jun1996, Issue 55, pS-14 

    Although the fetal aorta expresses a substantial amount of angiotensin II type 2 receptors, the expression level of angiotensin II type 2 receptors in the adult aorta and cultured vascular smooth muscle cells is very low or even absent. Prolonged serum depletion (6 to 8 days) with a supplement...

  • Factors correlated with plasma renin activity in general Japanese population. Abiko, Hiroshi; Konta, Tsuneo; Hao, Zhimei; Takasaki, Satoshi; Suzuki, Kazuko; Ichikawa, Kazunobu; Ikeda, Ami; Shibata, Yoko; Takeishi, Yasuchika; Kawata, Sumio; Kato, Takeo; Kubota, Isao // Clinical & Experimental Nephrology;Apr2009, Vol. 13 Issue 2, p130 

    The renin-angiotensin-aldosterone system plays a pivotal role in regulation of blood pressure and electrolyte homeostasis and is a target in the treatment of hypertension and renal diseases. However, the factors correlated with plasma renin activity (PRA) are unclarified in general Japanese...

  • Neural Control of Blood Pressure: Focusing on Capsaicin-Sensitive Sensory Nerves. Wang, Youping; Wang, Donna H. // Cardiovascular & Haematological Disorders - Drug Targets;Mar2007, Vol. 7 Issue 1, p37 

    Hypertension is a major risk factor leading to devastating cardiovascular events such as myocardial infarction, stroke, heart failure, and renal failure. Despite intensive research in this area, mechanisms underlying essential hypertension remain to be defined. Accumulating evidence indicates...

  • Angiotensin II Shifts Insulin Signaling Into Vascular Remodeling From Glucose Metabolism in Vascular Smooth Muscle Cells. Hitomi, Hirofumi; Kaifu, Kumiko; Fujita, Yoshiko; Sofue, Tadashi; Nakano, Daisuke; Moriwaki, Kumiko; Hara, Taiga; Kiyomoto, Hideyasu; Kohno, Masakazu; Kobori, Hiroyuki; Nishiyama, Akira // American Journal of Hypertension;Oct2011, Vol. 24 Issue 10, p1149 

    BackgroundTo clarify the role of angiotensin II (Ang II) in insulin-induced arteriosclerosis, we examined the effects of Ang II on insulin-induced mitogen-activated protein (MAP) kinase activation and cellular hypertrophy in rat vascular smooth muscle cells (VSMCs).MethodsPhosphorylated MAP...

  • Estrogen Metabolite 2-methoxyestradiol Prevents Hypertension in Deoxycorticosterone Acetate-salt Rats. Yuan, Wensu; Yu, Yueyi; Li, Jingjing; Singh, Pavneet; Li, Dong; Gui, Yu; Zheng, Xi-Long // Cardiovascular Drugs & Therapy;Feb2013, Vol. 27 Issue 1, p17 

    Purpose: Our early work showed that the estrogen metabolite 2-methoxyestradiol (2ME) inhibits proliferation of vascular smooth muscle cells (SMCs) and vascular contractility through an endothelium-dependent mechanism. The aim of this study was to examine whether 2ME prevents the development of...

  • iPLA2� Overexpression in Smooth Muscle Exacer�ates Angiotensin II-Induced Hypertension and Vascular Remodeling. Calderon, Lindsay E.; Shu Liu; Wen Su; Zhongwen Xie; Zhenheng Guo; Eberhard, Wanda; Gong, Ming C. // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Objectives: Calcium independent group VIA phospholipase A2 (iPLA2�) is up-regulated in vascular smooth muscle cells in some diseases, but whether the up-regulated iPLA2� affects vascular morphology and blood pressure is unknown. The current study addresses this question by evaluating...

  • iPLA2β Overexpression in Smooth Muscle Exacerβates Angiotensin II-Induced Hypertension and Vascular Remodeling. Calderon, Lindsay E.; Shu Liu; Wen Su; Zhongwen Xie; Zhenheng Guo; Eberhard, Wanda; Gong, Ming C. // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Objectives: Calcium independent group VIA phospholipase A2 (iPLA2β) is up-regulated in vascular smooth muscle cells in some diseases, but whether the up-regulated iPLA2β affects vascular morphology and blood pressure is unknown. The current study addresses this question by evaluating the...

  • Not just angiotensinases: new roles for the angiotensin-converting enzymes. Lambert, Daniel W.; Clarke, Nicola E.; Turner, Anthony J. // Cellular & Molecular Life Sciences;Jan2010, Vol. 67 Issue 1, p89 

    The renin-angiotensin system (RAS) is a critical regulator of blood pressure and fluid homeostasis. Angiotensin II, the primary bioactive peptide of the RAS, is generated from angiotensin I by angiotensin-converting enzyme (ACE). A homologue of ACE, ACE2, is able to convert angiotensin II to a...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics